
Ready for remote: eCOA and EDC
Whilst a push towards entirely decentralized studies is the end goal nowadays; the industry recognizes the best way forward currently is within a hybrid trial
EDC
One size does not fit all
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections
eTMF
Essential document collection
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Managed Service Model for MDR
Migration, Consulting and Customization for your MDR
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
Whilst a push towards entirely decentralized studies is the end goal nowadays; the industry recognizes the best way forward currently is within a hybrid trial
Want to save time and enhance your clinical trials? Learn how to take your data capture to the next level thanks to our tips and
How to leverage data linkage to get better outcomes? EvidentIQ, a leading clinical data science group, announced its partnership with Feel Therapeutics, a digital therapeutics
How to leverage both patient centricity and digital innovation in clinical research? Over the past years, clinical research has entered a new area with an
On December 7th, Andreas Weber, Group CEO at EvidentIQ, sat down with Natalie Yeadon, Co-Founder & CEO at Impetus Digital to discuss hybrid vs. fully decentralized trials,
Looking for a way to digitize the Informed Consent process and facilitate your clinical trials? On November 18th our eConsent webinar took place. We showed
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2023 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us: